Try our Advanced Search for more refined results

Merck Won't Join Inversion Craze, CEO Says

By Ama Sarfo (July 29, 2014, 3:57 PM EDT) -- Pharmaceutical companies are heavily represented in this year's roster of inversion deals, but Merck & Co. Inc. won't be joining the pack according to CEO Kenneth Frazier, who in an earnings call Tuesday said the drug giant isn't interested in seeking an inversion deal....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!